1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical Iodine Radioisotopes Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Medical Iodine Radioisotopes by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Medical Iodine Radioisotopes by Country/Region, 2018, 2022 & 2029
2.2 Medical Iodine Radioisotopes Segment by Type
2.2.1 Iodine-131
2.2.2 Iodine-125
2.2.3 Others
2.3 Medical Iodine Radioisotopes Sales by Type
2.3.1 Global Medical Iodine Radioisotopes Sales Market Share by Type (2018-2023)
2.3.2 Global Medical Iodine Radioisotopes Revenue and Market Share by Type (2018-2023)
2.3.3 Global Medical Iodine Radioisotopes Sale Price by Type (2018-2023)
2.4 Medical Iodine Radioisotopes Segment by Application
2.4.1 Radiation Therapy
2.4.2 Radioactive Label
2.5 Medical Iodine Radioisotopes Sales by Application
2.5.1 Global Medical Iodine Radioisotopes Sale Market Share by Application (2018-2023)
2.5.2 Global Medical Iodine Radioisotopes Revenue and Market Share by Application (2018-2023)
2.5.3 Global Medical Iodine Radioisotopes Sale Price by Application (2018-2023)
3 Global Medical Iodine Radioisotopes by Company
3.1 Global Medical Iodine Radioisotopes Breakdown Data by Company
3.1.1 Global Medical Iodine Radioisotopes Annual Sales by Company (2018-2023)
3.1.2 Global Medical Iodine Radioisotopes Sales Market Share by Company (2018-2023)
3.2 Global Medical Iodine Radioisotopes Annual Revenue by Company (2018-2023)
3.2.1 Global Medical Iodine Radioisotopes Revenue by Company (2018-2023)
3.2.2 Global Medical Iodine Radioisotopes Revenue Market Share by Company (2018-2023)
3.3 Global Medical Iodine Radioisotopes Sale Price by Company
3.4 Key Manufacturers Medical Iodine Radioisotopes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Iodine Radioisotopes Product Location Distribution
3.4.2 Players Medical Iodine Radioisotopes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Medical Iodine Radioisotopes by Geographic Region
4.1 World Historic Medical Iodine Radioisotopes Market Size by Geographic Region (2018-2023)
4.1.1 Global Medical Iodine Radioisotopes Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Medical Iodine Radioisotopes Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Medical Iodine Radioisotopes Market Size by Country/Region (2018-2023)
4.2.1 Global Medical Iodine Radioisotopes Annual Sales by Country/Region (2018-2023)
4.2.2 Global Medical Iodine Radioisotopes Annual Revenue by Country/Region (2018-2023)
4.3 Americas Medical Iodine Radioisotopes Sales Growth
4.4 APAC Medical Iodine Radioisotopes Sales Growth
4.5 Europe Medical Iodine Radioisotopes Sales Growth
4.6 Middle East & Africa Medical Iodine Radioisotopes Sales Growth
5 Americas
5.1 Americas Medical Iodine Radioisotopes Sales by Country
5.1.1 Americas Medical Iodine Radioisotopes Sales by Country (2018-2023)
5.1.2 Americas Medical Iodine Radioisotopes Revenue by Country (2018-2023)
5.2 Americas Medical Iodine Radioisotopes Sales by Type
5.3 Americas Medical Iodine Radioisotopes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Iodine Radioisotopes Sales by Region
6.1.1 APAC Medical Iodine Radioisotopes Sales by Region (2018-2023)
6.1.2 APAC Medical Iodine Radioisotopes Revenue by Region (2018-2023)
6.2 APAC Medical Iodine Radioisotopes Sales by Type
6.3 APAC Medical Iodine Radioisotopes Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Medical Iodine Radioisotopes by Country
7.1.1 Europe Medical Iodine Radioisotopes Sales by Country (2018-2023)
7.1.2 Europe Medical Iodine Radioisotopes Revenue by Country (2018-2023)
7.2 Europe Medical Iodine Radioisotopes Sales by Type
7.3 Europe Medical Iodine Radioisotopes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical Iodine Radioisotopes by Country
8.1.1 Middle East & Africa Medical Iodine Radioisotopes Sales by Country (2018-2023)
8.1.2 Middle East & Africa Medical Iodine Radioisotopes Revenue by Country (2018-2023)
8.2 Middle East & Africa Medical Iodine Radioisotopes Sales by Type
8.3 Middle East & Africa Medical Iodine Radioisotopes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Iodine Radioisotopes
10.3 Manufacturing Process Analysis of Medical Iodine Radioisotopes
10.4 Industry Chain Structure of Medical Iodine Radioisotopes
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Iodine Radioisotopes Distributors
11.3 Medical Iodine Radioisotopes Customer
12 World Forecast Review for Medical Iodine Radioisotopes by Geographic Region
12.1 Global Medical Iodine Radioisotopes Market Size Forecast by Region
12.1.1 Global Medical Iodine Radioisotopes Forecast by Region (2024-2029)
12.1.2 Global Medical Iodine Radioisotopes Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Medical Iodine Radioisotopes Forecast by Type
12.7 Global Medical Iodine Radioisotopes Forecast by Application
13 Key Players Analysis
13.1 Jubilant DraxImage
13.1.1 Jubilant DraxImage Company Information
13.1.2 Jubilant DraxImage Medical Iodine Radioisotopes Product Portfolios and Specifications
13.1.3 Jubilant DraxImage Medical Iodine Radioisotopes Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Jubilant DraxImage Main Business Overview
13.1.5 Jubilant DraxImage Latest Developments
13.2 NTP Radioisotopes
13.2.1 NTP Radioisotopes Company Information
13.2.2 NTP Radioisotopes Medical Iodine Radioisotopes Product Portfolios and Specifications
13.2.3 NTP Radioisotopes Medical Iodine Radioisotopes Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 NTP Radioisotopes Main Business Overview
13.2.5 NTP Radioisotopes Latest Developments
13.3 McMaster University
13.3.1 McMaster University Company Information
13.3.2 McMaster University Medical Iodine Radioisotopes Product Portfolios and Specifications
13.3.3 McMaster University Medical Iodine Radioisotopes Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 McMaster University Main Business Overview
13.3.5 McMaster University Latest Developments
13.4 Rosatom State Corporation
13.4.1 Rosatom State Corporation Company Information
13.4.2 Rosatom State Corporation Medical Iodine Radioisotopes Product Portfolios and Specifications
13.4.3 Rosatom State Corporation Medical Iodine Radioisotopes Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Rosatom State Corporation Main Business Overview
13.4.5 Rosatom State Corporation Latest Developments
13.5 IRE-ELiT
13.5.1 IRE-ELiT Company Information
13.5.2 IRE-ELiT Medical Iodine Radioisotopes Product Portfolios and Specifications
13.5.3 IRE-ELiT Medical Iodine Radioisotopes Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 IRE-ELiT Main Business Overview
13.5.5 IRE-ELiT Latest Developments
14 Research Findings and Conclusion
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/